A customer reported a positive result with a cyclesure® 24 biological indicator (bi) after a completed sterrad® 100s short cycle.The bi was incubated for 24 hours.The chemical indicator (ci) changed color correctly.A subsequent bi was negative.The affected load was released and used on patient(s).There was no report of infection, injury or harm to patient(s) associated with this issue.Although there is no report of patient injury or harm and no prior incidents have resulted in serious injury, advanced sterilization products (asp) has determined in this situation sterility cannot be assured.Therefore, as a matter of policy asp had decided to report all incidents of positive cyclesure® 24 biological indicators when the affected loads have not been reprocessed.
|
Asp investigation summary: the investigation included a review of the device history record (dhr), trending of lot number, system risk analysis (sra), visual analysis, retains analysis and concomitant product evaluation.¿ trending analysis by lot number was reviewed from 05/25/2017 to 10/10/2017 and trending was not exceeded.¿ the sra indicates the risk associated with exposure to biohazardous, pathogenic or infectious material is "low." ¿ an issue with the concomitant sterrad® 100s is unlikely since the cycle passed and the ci disc changed color correctly.Additionally, the asp field service engineer serviced the unit and confirmed it was working within specifications.The assignable cause could not be verified.It is unlikely the suspected positive bi was caused by a manufacturing issue as the cyclesure® retains met functional specification, dhr review found no anomalies that would contribute to a positive bi result and lot history review found trending was not exceeded in this lot.Also, no manufacturing anomalies were observed in the returned suspect bi that would contribute to a positive bi result.An issue with sterrad® performance is also unlikely as the cycle passed and the customer stated subsequent bi was negative for growth.As a result, there is not an issue with product performance when used per the instructions for use (ifu).The issue will continue to be tracked and trended.
|
The dhr was reviewed and the involved lot met manufacturer specifications at the time of release.No anomalies were observed that would contribute to the customer's experienced issue.The single cyclesure 24 bi was returned for visual inspection.The ci disc is yellow which indicates exposure to hydrogen peroxide, the cap is pressed down, the vial is crushed, and there is yellow media in the vial.The suspected positive growth result was observed.No manufacturing related anomalies observed.Thirty-two retains bis were subject to functional evaluation.All thirty-two bis met specification.
|